The role of antigen specificity in the binding of murine monoclonal anti-DNA antibodies to microparticles from apoptotic cells

Clinical Immunology

Volumn 154, Issue 2, 2014, Pages 178-187

  Ullal, Anirudh J ^a   Marion, Tony N ^b   Pisetsky, David S ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Anti DNA; Apoptosis; Autoimmunity; Lupus; Microvesicle

Indexed keywords

DEOXYRIBONUCLEASE; DNA ANTIBODY; DOUBLE STRANDED DNA; MONOCLONAL ANTIBODY; SINGLE STRANDED DNA;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; IMMUNOCHEMISTRY; JURKAT CELL LINE; MEMBRANE MICROPARTICLE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL;

ANTI-DNA;; APOPTOSIS; AUTOIMMUNITY;; LUPUS;; MICROVESICLE;;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; APTAMERS, NUCLEOTIDE; CELL-DERIVED MICROPARTICLES; EPITOPES; MICE;

EID: 84908386907     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.05.007     Document Type: Article

References (41)

1. Hahn B.H. Antibodies to DNA. N. Engl. J. Med. 1998, 338:1359-1368.
2. Tsokos G.C. Systemic lupus erythematosus. N. Engl. J. Med. 2011, 365:2110-2121.
3. Jang Y.J., Stollar B.D. Anti-DNA antibodies: aspects of structure and pathogenicity. Cell. Mol. Life Sci. 2003, 60:309-320.
4. Mortensen E.S., Rekvig O.P. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J. Am. Soc. Nephrol. 2009, 20:696-704.
5. van der Vlag J., Berden J.H. Lupus nephritis: role of antinucleosome autoantibodies. Semin. Nephrol. 2011, 31:376-389.
6. Koffler D., Agnello V., Thoburn R., Kunkel H.G. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J. Exp. Med. 1971, 134:169-179.
7. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., Parroche P., Drabic S., Golenbock D., Sirois C., Hua J., An L.L., Audoly L., La Rosa G., Bierhaus A., Naworth P., Marshak-Rothstein A., Crow M.K., Fitzgerald K.A., Latz E., Kiener P.A., Coyle A.J. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat. Immunol. 2007, 8:487-496.
8. Vallin H., Perers A., Alm G.V., Ronnblom L. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus. J. Immunol. 1999, 163:6306-6313.
9. Shrivastav M., Niewold T.B. Nucleic acid sensors and type i interferon production in systemic lupus erythematosus. Front. Immunol. 2013, 4:319.
10. Galluzzi L., Vitale I., Abrams J.M., Alnemri E.S., Baehrecke E.H., Blagosklonny M.V., Dawson T.M., Dawson V.L., El-Deiry W.S., Fulda S., Gottlieb E., Green D.R., Hengartner M.O., Kepp O., Knight R.A., Kumar S., Lipton S.A., Lu X., Madeo F., Malorni W., Mehlen P., Nunez G., Peter M.E., Piacentini M., Rubinsztein D.C., Shi Y., Simon H.U., Vandenabeele P., White E., Yuan J., Zhivotovsky B., Melino G., Kroemer G. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ. 2012, 19:107-120.
11. Pisetsky D.S. The translocation of nuclear molecules during inflammation and cell death. Antioxid. Redox Signal. 2014, 20:1117-1125.
12. Shao W.H., Cohen P.L. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res. Ther. 2011, 13:202.
13. Holdenrieder S., Stieber P. Clinical use of circulating nucleosomes. Crit. Rev. Clin. Lab. Sci. 2009, 46:1-24.
14. Johansson P.I., Windelov N.A., Rasmussen L.S., Sorensen A.M., Ostrowski S.R. Blood levels of histone-complexed DNA fragments are associated with coagulopathy, inflammation and endothelial damage early after trauma. J. Emerg. Trauma Shock 2013, 6:171-175.
15. Zeerleder S., Zwart B., Wuillemin W.A., Aarden L.A., Groeneveld A.B., Caliezi C., van Nieuwenhuijze A.E., van Mierlo G.J., Eerenberg A.J., Lammle B., Hack C.E. Elevated nucleosome levels in systemic inflammation and sepsis. Crit. Care Med. 2003, 31:1947-1951.
16. Luger K., Dechassa M.L., Tremethick D.J. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair?. Nat. Rev. Mol. Cell Biol. 2012, 13:436-447.
17. Zentner G.E., Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat. Struct. Mol. Biol. 2013, 20:259-266.
18. Huang H., Chen H.W., Evankovich J., Yan W., Rosborough B.R., Nace G.W., Ding Q., Loughran P., Beer-Stolz D., Billiar T.R., Esmon C.T., Tsung A. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J. Immunol. 2013, 191:2665-2679.
19. Huang H., Evankovich J., Yan W., Nace G., Zhang L., Ross M., Liao X., Billiar T., Xu J., Esmon C.T., Tsung A. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011, 54:999-1008.
20. Lindau D., Ronnefarth V., Erbacher A., Rammensee H.G., Decker P. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus. Eur. J. Immunol. 2011, 41:669-681.
21. Buzas E.I., Gyorgy B., Nagy G., Falus A., Gay S. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol. 2014, 10:356-364.
22. Pisetsky D.S., Ullal A.J., Gauley J., Ning T.C. Microparticles as mediators and biomarkers of rheumatic disease. Rheumatology (Oxford) 2012, 51:1737-1746.
23. Berda-Haddad Y., Robert S., Salers P., Zekraoui L., Farnarier C., Dinarello C.A., Dignat-George F., Kaplanski G. Sterile inflammation of endothelial cell-derived apoptotic bodies is mediated by interleukin-1alpha. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20684-20689.
24. Lane J.D., Allan V.J., Woodman P.G. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells. J. Cell Sci. 2005, 118:4059-4071.
25. Reich C.F., Pisetsky D.S. The content of DNA and RNA in microparticles released by Jurkat and HL-60 cells undergoing in vitro apoptosis. Exp. Cell Res. 2009, 315:760-768.
26. Schiller M., Bekeredjian-Ding I., Heyder P., Blank N., Ho A.D., Lorenz H.M. Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis. Cell Death Differ. 2008, 15:183-191.
27. Suber T., Rosen A. Apoptotic cell blebs: repositories of autoantigens and contributors to immune context. Arthritis Rheum. 2009, 60:2216-2219.
28. Ullal A.J., Reich C.F., Clowse M., Criscione-Schreiber L.G., Tochacek M., Monestier M., Pisetsky D.S. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J. Autoimmun. 2011, 36:173-180.
29. Nielsen C.T., Ostergaard O., Stener L., Iversen L.V., Truedsson L., Gullstrand B., Jacobsen S., Heegaard N.H. Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum. 2012, 64:1227-1236.
30. Pisetsky D.S. Microparticles as autoantigens: making immune complexes big. Arthritis Rheum. 2012, 64:958-961.
31. Marion T.N., Lawton A.R., Kearney J.F., Briles D.E. Anti-DNA autoantibodies in (NZB X NZW)F1 mice are clonally heterogeneous, but the majority share a common idiotype. J. Immunol. 1982, 128:668-674.
32. Marion T.N., Tillman D.M., Jou N.T., Hill R.J. Selection of immunoglobulin variable regions in autoimmunity to DNA. Immunol. Rev. 1992, 128:123-149.
33. Tillman D.M., Jou N.T., Hill R.J., Marion T.N. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice. J. Exp. Med. 1992, 176:761-779.
34. Ullal A.J., Pisetsky D.S. The role of microparticles in the generation of immune complexes in murine lupus. Clin. Immunol. 2013, 146:1-9.
35. Neeli I., Richardson M.M., Khan S.N., Nicolo D., Monestier M., Radic M.Z. Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs. Mol. Immunol. 2007, 44:1914-1921.
36. Radic M., Marion T., Monestier M. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol. 2004, 172:6692-6700.
37. Seredkina N., Van Der Vlag J., Berden J., Mortensen E., Rekvig O.P. Lupus nephritis: enigmas, conflicting models and an emerging concept. Mol. Med. 2013, 19:161-169.
38. Krishnan M.R., Wang C., Marion T.N. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int. 2012, 82:184-192.
39. Martinez Valle F., Balada E., Ordi-Ros J., Vilardell-Tarres M. DNase 1 and systemic lupus erythematosus. Autoimmun. Rev. 2008, 7:359-363.
40. Napirei M., Ludwig S., Mezrhab J., Klockl T., Mannherz H.G. Murine serum nucleases-contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 2009, 276:1059-1073.
41. Thiyagarajan D., Fismen S., Seredkina N., Jacobsen S., Elung-Jensen T., Kamper A.L., Fenton C.G., Rekvig O.P., Mortensen E.S. Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of Toll like receptors and the Clec4e. PLoS One 2012, 7:e34080.